Cytogenetic effects of psychoactive drugs.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D002188:Cannabis / Q000633:toxicity; D002648:Child; D002675:Child, Preschool; D002707:Chlordiazepoxide / Q000633:toxicity; D002746:Chlorpromazine / Q000633:toxicity; D002869:Chromosome Aberrations; D002875:Chromosomes / Q000187:drug effects*; D006224:Cricetinae; D003975:Diazepam / Q000633:toxicity; D004330:Drosophila; D005260:Female; D005333:Fetus; D005826:Genetics, Medical; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007962:Leukocytes / Q000187:drug effects; D008094:Lithium / Q000633:toxicity; D008238:Lysergic Acid Diethylamide / Q000633:toxicity; D008253:Macaca mulatta; D008297:Male; D008431:Maternal-Fetal Exchange; D051379:Mice; D008875:Middle Aged; D009892:Opium / Q000633:toxicity; D010546:Perphenazine / Q000633:toxicity; D011247:Pregnancy; D011619:Psychotropic Drugs / Q000633:toxicity*; D051381:Rats
D011619:Psychotropic Drugs; D002707:Chlordiazepoxide; D009892:Opium; D008238:Lysergic Acid Diethylamide; D008094:Lithium; D010546:Perphenazine; D003975:Diazepam; D002746:Chlorpromazine